Author(s): Adler H.; Ferreira D.M.; Rylance J.; Gordon S.B.

Source: Clinical and Vaccine Immunology; Jun 2017; vol. 24 (no. 6)

Publication Date: Jun 2017

Publication Type(s): Review

Abstract:Immunity to pneumococcal infections is impaired in older people, and current vaccines are poorly protective against pneumococcal disease in this population. Naturally acquired immunity to pneumococcal capsular polysaccharides develops during childhood and is robust in young adults but deteriorates with advanced age. In particular, antibody levels and function are reduced in older people. Pneumococcal vaccines are recommended for people 65 years old. However, the benefits of polysaccharide and protein-conjugated vaccines in this population are small, because of both serotype replacement and incomplete protection against vaccine serotype pneumococcal disease. In this review, we overview the immune mechanisms by which naturally acquired and vaccine-induced pneumococcal capsular polysaccharide immunity declines with age, including altered colonization dynamics, reduced opsonic activity of antibodies (particularly IgM), and impaired mucosal immunity.

Copyright © 2017 American Society for Microbiology. All Rights Reserved.

Database: EMBASE

Leave a Reply

Your email address will not be published. Required fields are marked *